KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Interest Coverage Ratio (2019 - 2025)

Historic Interest Coverage Ratio for Aurinia Pharmaceuticals (AUPH) over the last 7 years, with Q3 2025 value amounting to 27.07.

  • Aurinia Pharmaceuticals' Interest Coverage Ratio rose 17830.39% to 27.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 15.81, marking a year-over-year increase of 34169.7%. This contributed to the annual value of 0.97 for FY2024, which is 9706.62% up from last year.
  • According to the latest figures from Q3 2025, Aurinia Pharmaceuticals' Interest Coverage Ratio is 27.07, which was up 17830.39% from 17.98 recorded in Q2 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Interest Coverage Ratio peaked at 160.32 during Q4 2021, and registered a low of 248.77 during Q2 2023.
  • Moreover, its 4-year median value for Interest Coverage Ratio was 1.26 (2024), whereas its average is 5.5.
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Interest Coverage Ratio soared by 9357.07% in 2024, and later skyrocketed by 152361.75% in 2025.
  • Aurinia Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 160.32 in 2021, then tumbled by 114.13% to 22.65 in 2023, then skyrocketed by 93.57% to 1.46 in 2024, then skyrocketed by 1958.42% to 27.07 in 2025.
  • Its Interest Coverage Ratio was 27.07 in Q3 2025, compared to 17.98 in Q2 2025 and 20.48 in Q1 2025.